|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 519/00 | |
| A61P 3/10 | |||
| A61K 31/4184 | |||
| A61K 31/415 | |||
| A61K 31/454 |
| (11) | Patento numeris | 2888005 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13830277.3 |
| Europos patento paraiškos padavimo data | 2013-08-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-07-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-04-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/055528 |
| Data | 2013-08-19 |
| (87) | Numeris | WO 2014/031515 |
| Data | 2014-02-27 |
| (30) | Numeris | Data | Šalis |
| 201261692018 P | 2012-08-22 | US |
| (72) |
APGAR, James, M., US
ARASAPPAN, Ashok, US
BIFTU, Tesfaye, US
CHEN, Ping, US
FENG, Danqing, US
GUIDRY, Erin, US
HICKS, Jacqueline, US
KEKEC, Ahmet, US
LEAVITT, Kenneth, US
LI, Bing, US
MCCRACKEN, Troy, US
SEBHAT, Iyassu, US
QIAN, Xiaoxia, US
WEI, Lan, US
WILKENING, Robert, US
WU, Zhicai, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | NOVEL AZABENZIMIDAZOLE HEXAHYDROFURO[3,2-B]FURAN DERIVATIVES |
| NOVEL AZABENZIMIDAZOLE HEXAHYDROFURO[3,2-B]FURAN DERIVATIVES |